Biotricity, Inc. (BTCY)
USD 0.35
(3.83%)
USD 0.35
(3.83%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | -14.09 Million USD | 24.46% |
| 2023 | -18.65 Million USD | 35.95% |
| 2022 | -29.13 Million USD | -88.05% |
| 2021 | -15.49 Million USD | -39.98% |
| 2020 | -11.06 Million USD | -28.8% |
| 2019 | -8.59 Million USD | 0.37% |
| 2018 | -8.62 Million USD | -10.43% |
| 2017 | -7.8 Million USD | -50.59% |
| 2016 | -5.18 Million USD | -5610.47% |
| 2015 | -90.81 Thousand USD | 0.28% |
| 2014 | -91.07 Thousand USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | -14.09 Million USD | 24.46% |
| 2024 Q1 | -3.41 Million USD | 26.95% |
| 2024 Q3 | -2.8 Million USD | 23.92% |
| 2024 Q4 | -4.18 Million USD | -48.94% |
| 2024 Q2 | -3.69 Million USD | -8.14% |
| 2023 Q3 | -4.51 Million USD | 3.74% |
| 2023 Q2 | -4.69 Million USD | 1.75% |
| 2023 FY | -18.65 Million USD | 35.95% |
| 2023 Q1 | -4.77 Million USD | 14.89% |
| 2023 Q4 | -4.67 Million USD | -3.43% |
| 2022 Q4 | -5.61 Million USD | 21.07% |
| 2022 Q3 | -7.1 Million USD | 33.88% |
| 2022 Q2 | -10.75 Million USD | -90.11% |
| 2022 Q1 | -5.65 Million USD | -3.37% |
| 2022 FY | -29.13 Million USD | -88.05% |
| 2021 Q1 | -3.15 Million USD | 31.34% |
| 2021 FY | -15.49 Million USD | -39.98% |
| 2021 Q2 | -2.96 Million USD | 6.18% |
| 2021 Q3 | -3.9 Million USD | -31.67% |
| 2021 Q4 | -5.47 Million USD | -40.29% |
| 2020 Q2 | -2 Million USD | 3.9% |
| 2020 Q3 | -2.37 Million USD | -18.07% |
| 2020 FY | -11.06 Million USD | -28.8% |
| 2020 Q1 | -2.08 Million USD | -14.65% |
| 2020 Q4 | -4.59 Million USD | -93.94% |
| 2019 Q1 | -2.42 Million USD | 13.29% |
| 2019 FY | -8.59 Million USD | 0.37% |
| 2019 Q3 | -2.17 Million USD | 0.21% |
| 2019 Q2 | -2.17 Million USD | 10.07% |
| 2019 Q4 | -1.82 Million USD | 16.1% |
| 2018 Q1 | -2.3 Million USD | -28.13% |
| 2018 Q2 | -1.45 Million USD | 36.83% |
| 2018 Q3 | -2.09 Million USD | -44.04% |
| 2018 Q4 | -2.79 Million USD | -33.21% |
| 2018 FY | -8.62 Million USD | -10.43% |
| 2017 Q1 | -1.04 Million USD | 17.69% |
| 2017 Q4 | -1.79 Million USD | 31.51% |
| 2017 FY | -7.8 Million USD | -50.59% |
| 2017 Q3 | -2.62 Million USD | -12.05% |
| 2017 Q2 | -2.34 Million USD | -124.24% |
| 2016 Q2 | -1.22 Million USD | -149.36% |
| 2016 FY | -5.18 Million USD | -5610.47% |
| 2016 Q4 | -1.26 Million USD | 14.93% |
| 2016 Q3 | -1.49 Million USD | -21.6% |
| 2016 Q1 | -492.01 Thousand USD | 0.0% |
| 2015 Q1 | -28.14 Thousand USD | 0.0% |
| 2015 Q2 | -21.07 Thousand USD | 25.11% |
| 2015 Q3 | -18.9 Thousand USD | 10.31% |
| 2015 FY | -90.81 Thousand USD | 0.28% |
| 2014 FY | -91.07 Thousand USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Acutus Medical, Inc. | -81.66 Million USD | 82.741% |
| Cerus Corporation | -37.48 Million USD | 62.404% |
| OrthoPediatrics Corp. | -20.97 Million USD | 32.801% |
| PetVivo Holdings, Inc. | -10.95 Million USD | -28.653% |
| Talis Biomedical Corporation | -62 Million USD | 77.27% |
| Vivos Therapeutics, Inc. | -13.58 Million USD | -3.764% |
| Inogen, Inc. | -102.44 Million USD | 86.243% |
| Spectral AI, Inc. | -20.85 Million USD | 32.414% |
| Nano-X Imaging Ltd. | -60.77 Million USD | 76.809% |
| CVRx, Inc. | -41.19 Million USD | 65.79% |
| DIH Holding US, Inc. Warrants | 640.19 Thousand USD | 2301.557% |
| Helius Medical Technologies, Inc. | -8.85 Million USD | -59.257% |
| Orthofix Medical Inc. | -151.39 Million USD | 90.69% |
| Venus Concept Inc. | -37.25 Million USD | 62.163% |
| Accelerate Diagnostics, Inc. | -61.61 Million USD | 77.126% |
| Bioventus Inc. | -156.23 Million USD | 90.979% |
| BrainsWay Ltd. | -4.19 Million USD | -235.818% |
| Envoy Medical, Inc. | -29.9 Million USD | 52.875% |
| electroCore, Inc. | -18.83 Million USD | 25.166% |
| IceCure Medical Ltd | -14.65 Million USD | 3.806% |
| Lucid Diagnostics Inc. | -52.66 Million USD | 73.238% |
| Monogram Orthopaedics, Inc. | -13.74 Million USD | -2.54% |
| MaxCyte, Inc. | -37.92 Million USD | 62.834% |
| NeuroOne Medical Technologies Corporation | -11.85 Million USD | -18.844% |
| Nexalin Technology, Inc. | -4.64 Million USD | -203.187% |
| PAVmed Inc | -64.17 Million USD | 78.038% |
| Rapid Micro Biosystems, Inc. | -52.46 Million USD | 73.137% |
| RxSight, Inc. | -48.6 Million USD | 71.004% |
| Sight Sciences, Inc. | -55.54 Million USD | 74.626% |
| SI-BONE, Inc. | -43.33 Million USD | 67.477% |
| TELA Bio, Inc. | -46.66 Million USD | 69.796% |
| TriSalus Life Sciences, Inc. | -59.03 Million USD | 76.127% |
| Treace Medical Concepts, Inc. | -49.52 Million USD | 71.542% |
| LivaNova PLC | 17.54 Million USD | 180.328% |
| 908 Devices Inc. | -36.39 Million USD | 61.278% |
| Alphatec Holdings, Inc. | -186.63 Million USD | 92.448% |
| Nemaura Medical Inc. | -14.14 Million USD | 0.35% |
| NeuroPace, Inc. | -32.95 Million USD | 57.233% |
| LENSAR, Inc. | -14.38 Million USD | 2.007% |
| Apyx Medical Corporation | -18.71 Million USD | 24.682% |
| Cutera, Inc. | -162.83 Million USD | 91.344% |
| STRATA Skin Sciences, Inc. | -10.83 Million USD | -30.141% |
| BioSig Technologies, Inc. | -29.04 Million USD | 51.468% |
| Anika Therapeutics, Inc. | -82.66 Million USD | 82.951% |
| ClearPoint Neuro, Inc. | -22.08 Million USD | 36.193% |
| Integra LifeSciences Holdings Corporation | 67.74 Million USD | 120.806% |
| Axonics, Inc. | -6.08 Million USD | -131.509% |
| Outset Medical, Inc. | -172.79 Million USD | 91.843% |
| IRIDEX Corporation | -9.57 Million USD | -47.276% |
| PROCEPT BioRobotics Corporation | -105.89 Million USD | 86.691% |
| IRadimed Corporation | 17.19 Million USD | 181.978% |
| Tivic Health Systems, Inc. | -8.24 Million USD | -70.964% |
| INVO Bioscience, Inc. | -8.03 Million USD | -75.42% |
| Telesis Bio, Inc. | -47.72 Million USD | 70.467% |
| Viemed Healthcare, Inc. | 10.24 Million USD | 237.599% |
| Varex Imaging Corporation | -47.7 Million USD | 70.452% |
| Quipt Home Medical Corp. | -2.78 Million USD | -406.26% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -24.883% |
| Pulmonx Corporation | -60.84 Million USD | 76.835% |
| Dynatronics Corporation | -2.69 Million USD | -422.452% |
| Modular Medical, Inc. | -17.47 Million USD | 19.323% |
| ReShape Lifesciences Inc. | -11.38 Million USD | -23.775% |
| Semler Scientific, Inc. | 20.58 Million USD | 168.475% |
| InMode Ltd. | 197.91 Million USD | 107.121% |
| Bruker Corporation | 427.2 Million USD | 103.299% |
| Cytosorbents Corporation | -28.5 Million USD | 50.559% |
| DexCom, Inc. | 541.5 Million USD | 102.603% |
| Align Technology, Inc. | 445.05 Million USD | 103.167% |
| Viveve Medical, Inc. | -22.02 Million USD | 36.014% |
| ZimVie Inc. | -393.28 Million USD | 96.416% |
| Movano Inc. | -29.28 Million USD | 51.869% |
| Cytek Biosciences, Inc. | -12.14 Million USD | -16.021% |
| Nexalin Technology, Inc. | -4.64 Million USD | -203.187% |
| DIH Holdings US, Inc. Class A Common Stock | 640.19 Thousand USD | 2301.557% |
| Tandem Diabetes Care, Inc. | -222.61 Million USD | 93.669% |
| Profound Medical Corp. | -28.56 Million USD | 50.666% |
| Insulet Corporation | 206.3 Million USD | 106.832% |
| enVVeno Medical Corporation | -23.51 Million USD | 40.065% |
| Surmodics, Inc. | -11.54 Million USD | -22.113% |
| iCAD, Inc. | -4.84 Million USD | -190.784% |
| Nuwellis, Inc. | -20.2 Million USD | 30.257% |
| iRhythm Technologies, Inc. | -123.4 Million USD | 88.579% |
| Aethlon Medical, Inc. | -12.2 Million USD | -15.45% |
| InspireMD, Inc. | -19.91 Million USD | 29.231% |
| PAVmed Inc. | -64.17 Million USD | 78.038% |
| BIOLASE, Inc. | -20.63 Million USD | 31.687% |
| Beyond Air, Inc. | -60.24 Million USD | 76.604% |
| FONAR Corporation | 10.56 Million USD | 233.375% |
| AxoGen, Inc. | -21.71 Million USD | 35.097% |
| Vivani Medical, Inc. | -25.65 Million USD | 45.056% |
| Tactile Systems Technology, Inc. | 28.51 Million USD | 149.428% |
| Inari Medical, Inc. | -1.63 Million USD | -761.509% |
| UFP Technologies, Inc. | 44.92 Million USD | 131.374% |
| QT Imaging Holdings, Inc. | -5.13 Million USD | -174.618% |
| Heart Test Laboratories, Inc. | -6.6 Million USD | -113.381% |
| Tenon Medical, Inc. | -15.58 Million USD | 9.542% |
| Autonomix Medical, Inc. Common Stock | -15.42 Million USD | 8.633% |
| Co-Diagnostics, Inc. | -35.33 Million USD | 60.11% |
| AdaptHealth Corp. | -678.89 Million USD | 97.924% |
| Sintx Technologies, Inc. | -8.25 Million USD | -70.654% |
| NanoVibronix, Inc. | -3.71 Million USD | -279.797% |
| Quanterix Corporation | -32.33 Million USD | 56.41% |
| Inspira Technologies Oxy B.H.N. Ltd. | -11.28 Million USD | -24.883% |
| Sensus Healthcare, Inc. | 485 Thousand USD | 3006.038% |
| Pacific Biosciences of California, Inc. | -306.73 Million USD | 95.405% |
| TransMedics Group, Inc. | -25.02 Million USD | 43.686% |
| ReWalk Robotics Ltd. | -22.13 Million USD | 36.32% |
| NeuroMetrix, Inc. | -6.52 Million USD | -115.856% |
| Hyperfine, Inc. | -44.23 Million USD | 68.14% |
| Establishment Labs Holdings Inc. | -78.5 Million USD | 82.046% |
| Biomerica, Inc. | -5.97 Million USD | -135.769% |
| Bone Biologics Corporation | -8.94 Million USD | -57.5% |
| AVITA Medical, Inc. | -39.16 Million USD | 64.016% |
| Bluejay Diagnostics, Inc. | -9.95 Million USD | -41.596% |
| Silk Road Medical, Inc | -55.74 Million USD | 74.716% |